Centessa Pharmaceuticals plc

Research Centessa Pharmaceuticals plc (CNTA) on Bullrun: market cap USD 6.27B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCNTA
• ExchangeNASDAQ
• CountryUnited Kingdom
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 6.27B
• Financial periodFY2025
• RevenueUSD 15.00M
• Net income-USD 197.53M
• Free cash flow-USD 194.19M

Valuation Snapshot

latest market cap is USD 6.27B.

About Centessa Pharmaceuticals plc

Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia.

Frequently asked questions

What is Centessa Pharmaceuticals plc's market cap?

Centessa Pharmaceuticals plc's market capitalization is USD 6.27B.

What does Centessa Pharmaceuticals plc do?

Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States.